Essity acquires distribution rights to Sorbact in Australia and New Zealand - Global Paper Money

Click here for Pulp & Paper Radio International

The Paperitalo Library

The Paperitalo Library

White Papers/Downloads

PM 40 Companies

Cellulose Community

Paperitalo Resources

Paperitalo Supplier Directory

onlyPulpandPaperJobs.com

The Paperitalo Library

Inside PaperMoney

Paperitalo/Media Kit

Nip Impressions

Departments

Disconnected Comparisons

Insider Trading

Current News

Culture & Marketing

Corporate Finance

Labor & Union Actions

Major Expenditures

Market News of Note

Mergers & Acquisitions

Major Announcements

Operations Announcements

Facility Closures/Reductions

In Closing

Reference Library

AM Best Insurance News

Delaware Chancery Court

Fiduciary Developments

ICC News and Proceedings

Key Interest Rates

WTO News and Proceedings

Member Options

About Paper Money

Essity acquires distribution rights to Sorbact in Australia and New Zealand

SWEDEN (News release) -- Essity is acquiring the distribution rights to the wound care technology Sorbact® in Australia and New Zealand from the Australian company Bayport Brands. In 2020, sales of Sorbact® in the region amounted to AUD 1.7m (approximately SEK 11m).

"This acquisition underlines our ambition to accelerate growth in advanced wound care, where we showed good organic sales growth during the second half of 2020. It is also a good fit for our strategy to establish a stronger presence in Australia and New Zealand, where we - in addition to our successful Medical Solutions operations - are also in the final phase of the acquisition of Asaleo Care," says Magnus Groth, President and CEO of Essity.

Sorbact® is a clinically established innovation for advanced wound care, which is manufactured and marketed by Abigo Medical. Essity acquired 75% of Abigo Medical in February 2020.

Sorbact® is used in wound care products to prevent and treat infections. It does this using a natural mode of action that binds bacteria and fungi. Sorbact® does not contain antiseptics or other toxic substances, which is positive for both the patient and the environment.

Readers, please tell your suppliers that you read Paperitalo Publications

Related Articles:

DS Smith extends deadline for takeover offer by Mondi

DS Smith completes acquisition of Bosis doo in Serbia

European Commission Greenlights Smurfit Kappa Group and WestRock Merger

Western Forest Products completes sale of ownership interest in newly formed mid-island partnership

International Paper closes in on £5bn deal for London-listed DS Smith

Kimberly-Clark to sell PPE business to Ansell for $640 million

South Carolina Ports Authority advances purchase of WestRock site in North Charleston

Billerud will sell its idled Wisconsin Rapids paper mill

RRD Strengthens Marketing Services with Strategic Acquisition of Digital & Print Marketing Businesses from Vericast

Weinig takes over grinding machine portfolio from Stähle-Hess

Login and voice your opinion!

Our Sponsors

Copyright © and Trademark PaperMoney ® 2006-2024 All Rights Reserved

A Paperitalo Publication/The Home of your Prospects (TM)

Copyright Statement | Privacy Statement | Terms of Service

Powered by Bondware

News Publishing Software

The browser you are using is outdated!

You may not be getting all you can out of your browsing experience
and may be open to security risks!

Consider upgrading to the latest version of your browser or choose on below: